I Holland Rolls out an Innovative New Packaging Solution to Eliminate Potential Tool Tip Damage?
I Holland has released a breakthrough new packaging solution to ensure its products arrive in perfect condition.
PrimePac tubes (patent pending), part of the company’s new portfolio of packaging, have been specifically designed with a ‘safety zone’ to hold tablet punches in position to stop damage to the tip face.
“One of the most important and fundamental problems when transporting tablet tooling is ensuring the punch tip face is undamaged. Any damage to the very delicate land area will result in reduction of punch life when the punch is placed under stress in operation,” explains Michael Oxford, R&D Engineer.
“Although our previous packaging tubes have served us well, we felt that re-designing them to incorporate an innovative safety zone ensures the quality of the product, knowing that it will arrive with the customer in the same quality condition that it left the factory. By designing the PrimePac range we can maintain our customer service and ensure the end user receives the best quality product available, something very important to I Holland.”
Current methods of packaging protection commonly used by punch and die manufacturers include foam inserts or cardboard inner tubes, which do not have the protective power of the new designed PrimePac solution. The new packaging tubes will be rolled out in the coming months.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance